Transcranial Magnetic Stimulation has been an FDA-approved depression treatment since 2008, but the field has advanced significantly in the years since. In 2026, TMS is more accessible, more precise, and available in more protocol variations than ever before. This guide covers the most important TMS advances 2026 — from accelerated protocols to expanded applications for mental disorders.
At Mind Brain Institute, we prescribe medication when it’s clinically indicated and offer advanced TMS therapy as an additional or alternative treatment based on individual psychiatric assessment.
Accelerated protocols — 5-day and one-day TMS
Perhaps the most important TMS therapy advancement in recent years is the development of accelerated protocols. Rather than the standard 20–30 sessions over 4–6 weeks, these compressed treatments deliver a full course in as few as 5 days:
- SAINT protocol (Stanford Accelerated Intelligent Neuromodulation Therapy) — FDA-cleared 2022. Ten sessions per day for 5 consecutive days, MRI- or QEEG-guided targeting.
- Five-Day Intensive — variants of accelerated iTBS delivered over 5 days
- One-Day TMS — highly compressed protocols for select patients
These are particularly valuable for working professionals, international patients, and those who cannot commit to weeks of daily visits.
QEEG-guided personalisation
Standard TMS uses fixed coordinates for coil placement. New developments in TMS therapy include using individual QEEG brain mapping to identify the specific location and frequency most likely to help a particular patient.
This personalisation approach — using each patient’s brainwave patterns to guide protocol selection — is one of the most important precision-medicine advances in psychiatric care.
Deep TMS for expanded indications
The BrainsWay H-coil family has expanded FDA-cleared indications significantly:
- Depression (2013)
- OCD (2018)
- Smoking cessation (2020)
- Anxious depression (2021)
For patients with these conditions, Deep TMS offers stimulation of deeper brain structures than standard rTMS coils can reach.
New applications for mental disorders
Recent research has explored TMS for a growing list of conditions:
- Post-Traumatic Stress Disorder (PTSD) — targeted protocols show promise for select patients
- Anxiety disorders — particularly for anxiety with comorbid depression
- Substance use disorders — alcohol, nicotine, cocaine
- Bipolar depression — protocols adapted to avoid manic switching
- Alzheimer’s-related depression and cognitive symptoms — early research
- Post-stroke recovery — motor and cognitive rehabilitation
These are at various stages of evidence maturity. TMS for mental disorders continues to expand as research accumulates.
Improved side effect profiles
Newer protocols and better patient screening have reduced the already low incidence of serious side effects. Modern TMS protocols show:
- Seizure risk approximately 1 in 30,000–70,000 sessions (or lower)
- Fewer patient-reported side effects in early sessions
- Better tolerability with theta burst protocols
Cost accessibility in India
TMS therapy cost in India has become more accessible as more clinics adopt the technology and as protocols become more efficient. Standard courses in India range from ₹30,000 to ₹90,000 — a fraction of the $10,000–$15,000 charged in the West.
For patients from outside Delhi or international patients, this cost differential combined with compressed protocols has enabled real medical tourism for mental health care.
At Mind Brain Institute, TMS therapy in Delhi integrates all of these advances into individualised treatment plans.
What’s on the near horizon
Research areas actively developing in 2026:
- Home-based low-intensity TMS (still investigational)
- AI-driven protocol optimisation using treatment response data
- Combined TMS + ketamine protocols for severe treatment-resistant depression
- Longer-term outcome data on accelerated protocols
For related reading on approaching depression treatment, see our companion post on how to cure depression.
FAQ
What are the latest advances in TMS therapy in 2026?
Accelerated protocols (SAINT, 5-day, one-day), QEEG-guided personalisation, expanded FDA indications for Deep TMS, and improved cost accessibility.
How has TMS treatment improved for mental disorders?
Shorter protocols, better targeting, expanded indications for OCD/anxiety/addiction, and lower cost — all making advanced care more accessible.
What mental health conditions can advanced TMS therapy treat?
FDA-cleared for depression, OCD, anxious depression, and smoking cessation. Research supports use for PTSD, addiction, and bipolar depression in select patients.
Is TMS therapy becoming more personalised?
Yes. QEEG-guided targeting and individualised protocol selection are increasingly standard in advanced clinics.
What is the future of TMS treatment for depression and other mental disorders?
Continued expansion of accelerated protocols, AI-driven personalisation, combined therapies (TMS + ketamine, TMS + neurofeedback), and expanded regulatory approvals for new
